Bicycle Therapeutics
About:
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Website: http://www.bicycletherapeutics.com
Twitter/X: bicycle_tx
Top Investors: Hercules Capital, Cambridge Innovation Capital, RA Capital Management, Venture Kick, Innovate UK
Description:
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
$1.1B
$50M to $100M
Cambridge, Cambridgeshire, United Kingdom
2009-01-01
info(AT)bicycletherapeutics.com
Christian Heinis, Gregory Winter
101-250
2024-05-23
Public
© 2025 bioDAO.ai